Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 2/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.34 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13070297 | 0.93 | THRB (0.37) | PDE4APDE4BPDE4CPDE4DTAAR1 | |
| SCHEMBL28493753 | 0.87 | NAAA (0.42) | NAAACYP1A2 | |
| SCHEMBL6515441 | 0.84 | PDE4A (0.36) | PDE4APDE4BPDE4CPDE4DTRIM24 | |
| SCHEMBL11008165 | 0.83 | THRB (0.35) | NPC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL10598952 | 0.81 | NAAA (0.36) | NAAATHRB | |
| SCHEMBL11007607 | 0.80 | NAAA (0.38) | ALDH1A1KMT2ANAAATHRBCYP1A2 | |
| SCHEMBL2704293 | 0.78 | THRB (0.39) | PDE4APDE4BPDE4CPDE4DTHRB | |
| SCHEMBL29170487 | 0.77 | THRB (0.39) | PDE4APDE4BPDE4CPDE4DKMT2A | |
| SCHEMBL190984 | 0.77 | NPC1 (0.52) | NPC1TAAR1NAAAEPHX1CYP1A2 | |
| SCHEMBL6381815 | 0.77 | NPC1 (0.52) | NPC1TAAR1NAAAEPHX1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919878-B1 | PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS | HOFFMANN LA ROCHE (CH) | 2010-09-08 | — | — | EP | claimed |
| US-RE46024-E1 | Thyroid hormone analogs | HOFFMANN-LA ROCHE INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-7807674-B2 | Thyroid hormone analogs | HOFFMANN-LA ROCHE INC. (US) | 2010-10-05 | — | — | US | disclosed |
| EP-1919878-B1 | PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS | HOFFMANN LA ROCHE (CH) | 2010-09-08 | — | — | EP | disclosed |
| JP-2010163491-A | FRAGRANCE COMPOSITION | KAO CORP | 2010-07-29 | — | — | JP | disclosed |
| US-20090005383-A1 | THYROID HORMONE ANALOGS | HOFFMANN-LA ROCHE INC. | 2009-01-01 | — | — | US | disclosed |
| US-7452882-B2 | Thyroid hormone analogs | HOFFMANN-LA ROCHE INC. (US) | 2008-11-18 | — | — | US | disclosed |
| US-20070032494-A1 | Thyroid hormone analogs | HOFFMANN-LA ROCHE INC. | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005383-A1 | THYROID HORMONE ANALOGS | THRA, THRB, TPO | NPC1 212/4885PDE4A 2427/4885PDE4B 2506/4885 |
| US-20070032494-A1 | Thyroid hormone analogs | THRA, THRB, TPO | NPC1 212/4885PDE4A 2427/4885PDE4B 2506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.